Effect of Aplidin in acute lymphoblastic leukaemia cells.
about
Adding pharmacogenomics to the development of new marine-derived anticancer agentsMulticenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma.Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximabNew drugs from the sea.Initial testing of aplidin by the pediatric pre-clinical testing program.Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development.Metabolite profiling of ascidian Styela plicata using LC-MS with multivariate statistical analysis and their antitumor activity.Antiangiogenic activity of aplidine, a new agent of marine originEstablishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin.Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.Antitumour and antiangiogenic effects of Aplidin in the 5TMM syngeneic models of multiple myelomaAplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.Extract from Arca granosa L. inhibits proliferation of human tumour cell lines with kidney and lung origin.Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin.Heparin and suramin alter plitidepsin uptake via inhibition of GPCR coupled signaling.Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin.New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials†.New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials
P2860
Q25254985-69C0018A-1C56-465A-8BDB-23F8499D860BQ33403802-D4D7F129-C6BD-4360-ADCE-2A5A008AF343Q35911656-FBF55BE4-F352-421E-8A1E-83F3F1CC484FQ36028697-237243C6-70CA-417C-BE61-3D7B1CF6EF30Q37421824-53D93FF2-8D4D-400D-9141-F4FF9CE75085Q37650544-4B4EDD1F-E650-4439-8C50-BAD391069F44Q38715058-D886D858-2EB5-4F89-9B44-C6C8514686B9Q38796073-526775BA-D0DD-4D7E-8213-A232D21D56ADQ38801730-4D5E22FB-A471-46F1-B74C-C5B2C19A9316Q39215411-D72CF3A5-1439-4713-B567-F5A441BB98D8Q39638460-AEFF137A-C1BF-4551-A404-C07621C6C9B8Q40090768-42890F20-EEAA-4F96-970F-0047198DC122Q40229132-760304D6-5DD5-4DDE-AF5D-F6857EE2D30CQ41360384-00EB1204-09A2-4047-9B50-4A2B70D87A81Q43236883-1007BE17-AC7A-4869-BE7E-E663D06DC4CCQ46803216-2B2E7D87-8EDD-47B7-8292-CC13CF8DC53EQ55712396-8991F6D7-DD09-4FA6-BFFD-5C9FF9BF71B5Q56864609-6B929F0A-4541-4C55-B88B-E485FCAD32B5
P2860
Effect of Aplidin in acute lymphoblastic leukaemia cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Effect of Aplidin in acute lymphoblastic leukaemia cells.
@ast
Effect of Aplidin in acute lymphoblastic leukaemia cells.
@en
type
label
Effect of Aplidin in acute lymphoblastic leukaemia cells.
@ast
Effect of Aplidin in acute lymphoblastic leukaemia cells.
@en
prefLabel
Effect of Aplidin in acute lymphoblastic leukaemia cells.
@ast
Effect of Aplidin in acute lymphoblastic leukaemia cells.
@en
P2093
P2860
P50
P356
P1476
Effect of Aplidin in acute lymphoblastic leukaemia cells
@en
P2093
G T Faircloth
M Serafini
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601130
P407
P577
2003-08-01T00:00:00Z